CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related...
138 insider purchases on record · latest filing 2025-10-27.
Insiders have also filed 55 sale transactions at CRMD.